ZDHHC9 and breast cancer: ZDHHC9-mediated palmitoylation maintains the stability and cell surface distribution of PD-L1, leading to immune escape of breast cancer cells [16], whereas overexpression of ZDHHC9 greatly inhibits the proliferation of colorectal cancer cells (21).